IL50522A - N-aryl-n(4-piperidinyl)-aryl-acetamides, their preparation and pharmaceutical compositions containing them - Google Patents

N-aryl-n(4-piperidinyl)-aryl-acetamides, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL50522A
IL50522A IL50522A IL5052276A IL50522A IL 50522 A IL50522 A IL 50522A IL 50522 A IL50522 A IL 50522A IL 5052276 A IL5052276 A IL 5052276A IL 50522 A IL50522 A IL 50522A
Authority
IL
Israel
Prior art keywords
aryl
acetamides
piperidinyl
preparation
pharmaceutical compositions
Prior art date
Application number
IL50522A
Other languages
English (en)
Other versions
IL50522A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL50522A0 publication Critical patent/IL50522A0/xx
Publication of IL50522A publication Critical patent/IL50522A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL50522A 1975-09-23 1976-09-21 N-aryl-n(4-piperidinyl)-aryl-acetamides, their preparation and pharmaceutical compositions containing them IL50522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
IL50522A0 IL50522A0 (en) 1976-11-30
IL50522A true IL50522A (en) 1979-09-30

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50522A IL50522A (en) 1975-09-23 1976-09-21 N-aryl-n(4-piperidinyl)-aryl-acetamides, their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
JP (1) JPS6016417B2 (xx)
AT (1) AT363935B (xx)
AU (1) AU510029B2 (xx)
BG (1) BG27543A3 (xx)
CA (1) CA1068271A (xx)
CH (1) CH628623A5 (xx)
CS (1) CS222663B2 (xx)
DE (1) DE2642856A1 (xx)
DK (1) DK150478C (xx)
ES (1) ES451768A1 (xx)
FI (1) FI61482C (xx)
FR (1) FR2325377A1 (xx)
GB (1) GB1539473A (xx)
GR (1) GR58469B (xx)
HU (1) HU172964B (xx)
IE (1) IE43802B1 (xx)
IL (1) IL50522A (xx)
IT (1) IT1073893B (xx)
LU (1) LU75837A1 (xx)
NL (1) NL187267C (xx)
NO (1) NO147672C (xx)
NZ (1) NZ181972A (xx)
PH (1) PH12497A (xx)
PL (2) PL117323B1 (xx)
PT (1) PT65631B (xx)
RO (1) RO70079A (xx)
SE (1) SE427839B (xx)
SU (1) SU747424A3 (xx)
YU (1) YU39973B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
WO2008128994A1 (en) * 2007-04-23 2008-10-30 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
MX2009011415A (es) 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Derivados de 4-alcoxipiridazina como antagonistas del receptor de dopamina 2 de rapida disociacion.
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
JP5417439B2 (ja) 2008-07-03 2014-02-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 5−ht6受容体アンタゴニストとしての置換された6−(1−ピペラジニル)−ピリダジン類
CN102171189B (zh) 2008-07-31 2013-11-20 詹森药业有限公司 作为快速解离多巴胺2受体拮抗剂的哌嗪-1-基-三氟甲基取代的吡啶

Also Published As

Publication number Publication date
SE427839B (sv) 1983-05-09
IL50522A0 (en) 1976-11-30
NL187267B (nl) 1991-03-01
GR58469B (en) 1977-10-14
PL117323B1 (en) 1981-07-31
AU1787876A (en) 1978-03-23
DK150478B (da) 1987-03-09
FR2325377A1 (fr) 1977-04-22
JPS6016417B2 (ja) 1985-04-25
PL192578A1 (pl) 1979-02-26
BG27543A3 (en) 1979-11-12
JPS5239683A (en) 1977-03-28
RO70079A (ro) 1982-10-26
HU172964B (hu) 1979-01-28
PT65631A (en) 1976-10-01
FI762698A (xx) 1977-03-24
ATA702976A (de) 1981-02-15
DK150478C (da) 1987-10-05
AU510029B2 (en) 1980-06-05
NL7610513A (nl) 1977-03-25
NO147672B (no) 1983-02-14
PH12497A (en) 1979-04-05
LU75837A1 (xx) 1977-05-04
NO763054L (no) 1977-03-24
FR2325377B1 (xx) 1980-04-18
YU233676A (en) 1983-01-21
FI61482B (fi) 1982-04-30
CS222663B2 (en) 1983-07-29
ES451768A1 (es) 1978-05-01
DE2642856A1 (de) 1977-03-24
SE7610501L (sv) 1977-03-24
DE2642856C2 (xx) 1990-06-21
IE43802L (en) 1977-03-23
NL187267C (nl) 1991-08-01
IT1073893B (it) 1985-04-17
YU39973B (en) 1985-06-30
DK427876A (da) 1977-03-24
CH628623A5 (en) 1982-03-15
GB1539473A (en) 1979-01-31
PT65631B (en) 1978-07-05
AT363935B (de) 1981-09-10
SU747424A3 (ru) 1980-07-23
NO147672C (no) 1983-05-25
IE43802B1 (en) 1981-06-03
CA1068271A (en) 1979-12-18
NZ181972A (en) 1978-07-28
FI61482C (fi) 1982-08-10

Similar Documents

Publication Publication Date Title
IL49204A0 (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL50632A (en) Pyridinyl-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
IL50176A0 (en) Novel tetrahydroisoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL48835A0 (en) New peptides,their preparation and pharmaceutical compositions containing them
IL49911A0 (en) New 5-aroylpyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL50047A0 (en) Novel peptides,their preparation and pharmaceutical compositions containing them
IL50690A0 (en) Novel benzisothiazole derivatives,their preparation and pharmaceutical compositions containing them
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49422A0 (en) 1-(3,3,3-triarylpropyl)-4-phenyl-4-piperidinemethanols,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL50522A (en) N-aryl-n(4-piperidinyl)-aryl-acetamides, their preparation and pharmaceutical compositions containing them
IL49280A0 (en) Novel benzophenones,their preparation and pharmaceutical compositions containing them
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
IL49991A (en) L-pyroglutamyl-l-prolinamide, its preparation and pharmaceutical compositions containing it
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL50156A (en) N,n-bis-isoquinolinoalkylamine derivatives, their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL49971A0 (en) New 2-benzoypranone derivatives,their preparation and pharmaceutical compositions containing them
IL50554A (en) 2,9-dioxatricyclodecanes,their preparation and pharmaceutical compositions containing them
IL52207A (en) Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them
IL49344A (en) 2-substituted-7-halo-1,8-maphthyridine compounds,processesfor preparing the same and pharmaceutical compositions containing the same
IL49239A (en) O-aminoethyl methylthiophenyl-ketoximes, their preparation and pharmaceutical compositions containing them